DoD Traumatic Brain Injury and Psychological Health, Clinical Trial Award
ID: 354261Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Procurement Contract

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354261
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Clinical Trial Award (CTA) to support clinical trials aimed at improving the treatment and prevention of traumatic brain injuries (TBI) and psychological health conditions among military personnel and veterans. This funding opportunity encourages proposals for clinical trials that can lead to significant advancements in healthcare products, technologies, and practice guidelines, with a total estimated funding of $58.9 million to support approximately 18 awards. Key deadlines include a pre-application submission by June 27, 2024, and a full application submission by October 3, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524STBIPHRP1_CTA_BAA_GG.pdf
    The Department of Defense (DOD) has announced the FY24 Traumatic Brain Injury and Psychological Health Clinical Trial Award (CTA) under its Broad Agency Announcement for Extramural Research. This program aims to enhance the prevention and treatment of traumatic brain injuries (TBI) and psychological health conditions among military personnel and veterans. The funding opportunity encourages research proposals focused on clinical trials that can provide significant advancements in these areas, with a total appropriation of $175 million for FY24. Key deadlines include the pre-application submission by June 27, 2024, and full application submission by October 3, 2024. Eligible applicants include extramural organizations such as academic institutions and biotechnology companies. Specific focus areas for research include preventive and assessment solutions for psychological conditions and TBIs, as well as novel treatment interventions. The application process is a two-step procedure, mandating a pre-application followed by a full application to be submitted through designated platforms. The CTA aims to foster collaborations between researchers and community organizations, employing Community-Based Participatory Research (CBPR) methods to ensure relevance and effectiveness in addressing the needs of service members and their families. Overall, this initiative reflects DOD’s commitment to improving health outcomes through robust research and clinical applications.
    Similar Opportunities
    DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Translational Research Award (TRA) to advance research aimed at improving care for psychological health conditions and traumatic brain injuries (TBI). This grant opportunity focuses on hypothesis-driven research that seeks to develop novel healthcare products, clinical practices, and technologies, with an emphasis on translational research that leads to practical applications in clinical settings. With an estimated total program funding of $17.05 million, the program anticipates awarding approximately 14 grants, with funding caps of $500,000 for smaller projects and $1 million for larger, more complex research initiatives. Interested applicants must submit a pre-application by June 27, 2024, and full applications by October 3, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DoD Traumatic Brain Injury and Psychological Health, Focused Program Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 (FY24) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Focused Program Award (FPA) to support multidisciplinary research aimed at addressing critical challenges related to psychological health conditions and traumatic brain injuries (TBI). The program seeks applications that propose collaborative research projects, with a strong emphasis on clinical applications, including health care products, technologies, and practice guidelines, while ensuring that each project aligns with a unifying overarching challenge relevant to military health. With an estimated total program funding of $46.5 million and the expectation of awarding approximately six grants, interested applicants must submit a pre-application by June 27, 2024, followed by a full application due by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Traumatic Brain Injury and Psychological Health, Emerging Topics Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Emerging Topics Research Award (TBIPHRP ETRA) to fund research addressing emerging topics related to traumatic brain injury (TBI) and psychological health within the military context. This grant aims to accelerate research that will lead to new clinical applications, healthcare products, and guidelines that benefit Service Members, Veterans, and their families, with a total estimated funding of $16 million for approximately nine awards. The program encourages collaborative research, particularly partnerships between early-career and experienced investigators, and supports both preclinical and clinical research, including clinical trials. Interested applicants must submit their proposals by October 3, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Psychedelic Treatment Research Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 Psychedelic Treatment Research Clinical Trial Award (PTRCTA) to support clinical trials evaluating treatments for post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) among U.S. Service Members using specific psychedelic substances. Applicants are required to propose studies that address at least one of the covered conditions and utilize one or more of the eligible psychedelic substances, including MDMA, psilocybin, and ibogaine, with trials ranging from small proof-of-concept studies to larger efficacy trials. With an estimated total program funding of $9.8 million and the expectation of awarding two grants, interested parties must submit pre-applications by September 20, 2024, and full applications by October 4, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD VRP, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering the FY24 Vision Clinical Trial Award to fund innovative clinical trials aimed at addressing eye injuries and visual dysfunctions related to military service. This grant opportunity supports early-phase clinical trials that evaluate new products, pharmacologic agents, and devices, with a focus on improving treatment outcomes for service-connected visual impairments. With an estimated total program funding of $2.56 million and an anticipated award amount of up to $1.6 million per application, interested applicants must submit their pre-applications by July 11, 2024, and full applications by November 8, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Toxic Exposures Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Toxic Exposures Clinical Trial Award under the Toxic Exposures Research Program (TERP). This grant aims to support the rapid implementation of clinical trials that address health outcomes related to military-related toxic exposures, with a focus on prevention, treatment, and management of associated symptoms and diseases. The program emphasizes the importance of collaboration between the Department of Defense and the Department of Veterans Affairs, seeking proposals that align with specific program goals and topic areas, such as neurotoxin exposure and Gulf War Illness. The total estimated funding for this initiative is $10.4 million, with applications due by November 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Multiple Sclerosis, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Multiple Sclerosis Clinical Trial Award to support clinical trials aimed at improving treatment and management of multiple sclerosis (MS). This funding opportunity encourages innovative trials that may include new pharmacologic agents, devices, or emerging technologies, with a total estimated program funding of $8 million and the expectation of awarding three grants. Eligible applicants include unrestricted entities, and the funding levels are set at a maximum of $2 million for small-scale trials and $4 million for larger-scale studies, with a pre-application deadline of June 10, 2024, and a full application deadline of October 7, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    CDMRP Neurofibromatosis Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Neurofibromatosis Clinical Trial Award to support innovative clinical trials aimed at addressing high-impact issues related to neurofibromatosis (NF), including NF1, NF2, and schwannomatosis. Applicants are required to present a clear clinical trial design, preliminary data, and access to suitable patient populations, with a focus on enhancing understanding, diagnosis, and treatment of NF to benefit service members, veterans, and the public. This funding opportunity, totaling approximately $1.6 million for the award, encourages collaborative proposals involving academia, industry, and military branches, with key deadlines for pre-applications on September 12, 2024, and full applications by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Toxic Exposures Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Toxic Exposures Translational Research Award (TRA) to support research on adverse health outcomes related to military toxic exposures. This grant aims to facilitate translational research that bridges basic science and clinical applications, focusing on developing diagnostics, treatment strategies, and understanding exposure mechanisms to improve health care for service members and their families. With an estimated total program funding of $12.8 million and the expectation of awarding six grants, applicants must submit a pre-application by August 13, 2024, followed by a full application due by November 7, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.